. | Women (n = 11) . | Men (n = 39) . | ||||
---|---|---|---|---|---|---|
Median . | First quarter–third quarter . | P-value . | Median . | First quarter–third quarter . | P-value . | |
t1 P | 76.0 | 72.0–88.0 | 0.236 | 80.0 | 72.0–88.0 | <0.001 |
t2 P | 76.0 | 68.0–80.0 | 72.0 | 68.0–76.0 | ||
t1 E | 11.0 | 8.0–13.0 | 0.058 | 10.0 | 10.0–13.0 | <0.001 |
t2 E | 6.0 | 6.0–10.0 | 6.0 | 6.0–10.0 | ||
t1 X1 | 35.0 | 26.0–40.0 | 0.067 | 36.0 | 27.0–42.0 | <0.001 |
t2 X1 | 29.0 | 21.0–33.0 | 25.0 | 22.0–38.0 | ||
t1 BDI | 22.0 | 14.0–26.0 | 0.007 | 13.0 | 9.0–17.0 | <0.001 |
t2 BDI | 8.0 | 2.0–15.0 | 6.0 | 3.0–10.0 | ||
t1 AIS | 22.0 | 20.0–27.0 | 0.028 | 24.0 | 18.0–32.0 | <0.001 |
t2 AIS | 31.0 | 24.0–36.0 | 28.0 | 20.0–35.0 |
. | Women (n = 11) . | Men (n = 39) . | ||||
---|---|---|---|---|---|---|
Median . | First quarter–third quarter . | P-value . | Median . | First quarter–third quarter . | P-value . | |
t1 P | 76.0 | 72.0–88.0 | 0.236 | 80.0 | 72.0–88.0 | <0.001 |
t2 P | 76.0 | 68.0–80.0 | 72.0 | 68.0–76.0 | ||
t1 E | 11.0 | 8.0–13.0 | 0.058 | 10.0 | 10.0–13.0 | <0.001 |
t2 E | 6.0 | 6.0–10.0 | 6.0 | 6.0–10.0 | ||
t1 X1 | 35.0 | 26.0–40.0 | 0.067 | 36.0 | 27.0–42.0 | <0.001 |
t2 X1 | 29.0 | 21.0–33.0 | 25.0 | 22.0–38.0 | ||
t1 BDI | 22.0 | 14.0–26.0 | 0.007 | 13.0 | 9.0–17.0 | <0.001 |
t2 BDI | 8.0 | 2.0–15.0 | 6.0 | 3.0–10.0 | ||
t1 AIS | 22.0 | 20.0–27.0 | 0.028 | 24.0 | 18.0–32.0 | <0.001 |
t2 AIS | 31.0 | 24.0–36.0 | 28.0 | 20.0–35.0 |
t1: first measuring point (before rehabilitation); t2: second measuring point (after rehabilitation); P: pulse rate recorded at the peak of cycloergometer training; E: level of exertion measured by the BS; X1: level of anxiety as a state measured by State-Trait Anxiety Inventory; BDI: level of depression measured by Beck Depression Inventory; AIS: level of acceptance of illness measured by Acceptance of Illness Scale. Bolded P-values show significant improvement between first and second measuring points (t1 vs t2) in particular areas (pulse rate, level of exertion, level of anxiety etc.). P-value <0.05 was adopted as a boundary for significance.
. | Women (n = 11) . | Men (n = 39) . | ||||
---|---|---|---|---|---|---|
Median . | First quarter–third quarter . | P-value . | Median . | First quarter–third quarter . | P-value . | |
t1 P | 76.0 | 72.0–88.0 | 0.236 | 80.0 | 72.0–88.0 | <0.001 |
t2 P | 76.0 | 68.0–80.0 | 72.0 | 68.0–76.0 | ||
t1 E | 11.0 | 8.0–13.0 | 0.058 | 10.0 | 10.0–13.0 | <0.001 |
t2 E | 6.0 | 6.0–10.0 | 6.0 | 6.0–10.0 | ||
t1 X1 | 35.0 | 26.0–40.0 | 0.067 | 36.0 | 27.0–42.0 | <0.001 |
t2 X1 | 29.0 | 21.0–33.0 | 25.0 | 22.0–38.0 | ||
t1 BDI | 22.0 | 14.0–26.0 | 0.007 | 13.0 | 9.0–17.0 | <0.001 |
t2 BDI | 8.0 | 2.0–15.0 | 6.0 | 3.0–10.0 | ||
t1 AIS | 22.0 | 20.0–27.0 | 0.028 | 24.0 | 18.0–32.0 | <0.001 |
t2 AIS | 31.0 | 24.0–36.0 | 28.0 | 20.0–35.0 |
. | Women (n = 11) . | Men (n = 39) . | ||||
---|---|---|---|---|---|---|
Median . | First quarter–third quarter . | P-value . | Median . | First quarter–third quarter . | P-value . | |
t1 P | 76.0 | 72.0–88.0 | 0.236 | 80.0 | 72.0–88.0 | <0.001 |
t2 P | 76.0 | 68.0–80.0 | 72.0 | 68.0–76.0 | ||
t1 E | 11.0 | 8.0–13.0 | 0.058 | 10.0 | 10.0–13.0 | <0.001 |
t2 E | 6.0 | 6.0–10.0 | 6.0 | 6.0–10.0 | ||
t1 X1 | 35.0 | 26.0–40.0 | 0.067 | 36.0 | 27.0–42.0 | <0.001 |
t2 X1 | 29.0 | 21.0–33.0 | 25.0 | 22.0–38.0 | ||
t1 BDI | 22.0 | 14.0–26.0 | 0.007 | 13.0 | 9.0–17.0 | <0.001 |
t2 BDI | 8.0 | 2.0–15.0 | 6.0 | 3.0–10.0 | ||
t1 AIS | 22.0 | 20.0–27.0 | 0.028 | 24.0 | 18.0–32.0 | <0.001 |
t2 AIS | 31.0 | 24.0–36.0 | 28.0 | 20.0–35.0 |
t1: first measuring point (before rehabilitation); t2: second measuring point (after rehabilitation); P: pulse rate recorded at the peak of cycloergometer training; E: level of exertion measured by the BS; X1: level of anxiety as a state measured by State-Trait Anxiety Inventory; BDI: level of depression measured by Beck Depression Inventory; AIS: level of acceptance of illness measured by Acceptance of Illness Scale. Bolded P-values show significant improvement between first and second measuring points (t1 vs t2) in particular areas (pulse rate, level of exertion, level of anxiety etc.). P-value <0.05 was adopted as a boundary for significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.